Test Price
7,800 AED✅ Home Collection Available
ONCOPRO 350 GENE TMB & MSI PROFILE Test in UAE | 7800 AED | 2026 DHA Guidelines
تحليل اونكوبرو 350 جين لقياس حمل الطفرات الورمية وحالة عدم استقرار الساتل الميكروي في الإمارات | 7800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي – دقة تشخيصية 99.9% مع شهادة ISO وضمان الامتثال لدولة الإمارات
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection for blood draws (where applicable) and VIP Mobile Phlebotomy; FFPE Block Cold-Chain Transport under ISO Certified Chain-of-Custody.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by DHA-licensed consultant.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Clinical Gatekeepers & Their Intent
Oncologist
Primary interpreter of TMB (tumor mutational burden) and MSI status to guide immunotherapy (e.g., pembrolizumab) and targeted therapy selection.
Molecular Pathologist
Validates FFPE tissue adequacy (>10% tumor nuclei), NGS quality metrics, and ensures concordance with histological findings.
Clinical Geneticist
Evaluates incidental germline findings, hereditary cancer syndromes (e.g., Lynch), and provides post-test genetic counseling.
Test Overview
The ONCOPRO 350 gene panel simultaneously profiles 350 cancer‑related genes and calculates Tumor Mutational Burden (TMB) together with Microsatellite Instability (MSI) status using advanced Next‑Generation Sequencing (NGS). هذا التحليل الجينومي الشامل يُعد حجر الزاوية في الطب الدقيق للأورام، مما يوجه العلاج المناعي والعلاجات الموجهة بناءً على البصمة الجزيئية للورم.
| Feature | Our ONCOPRO 350 Test | Closest Alternative (IHC‑MSI + Limited Panel) |
|---|---|---|
| Precision & Depth | 350 genes NGS + quantitative TMB + MSI (PCR‑confirmed) | MSI by IHC only; gene panel ≤50 genes, no TMB |
| Methodology | NGS, Calculation Algorithms, Derived Ratios | Immunohistochemistry & PCR‑based sequencing |
| Turnaround Time | 45 Working Days | 10–14 days (limited scope) |
| Cost | 7800 AED | ~3200 AED (incomplete profiling) |
Physician Insights & Safety Protocol
“As an oncologist, I view the ONCOPRO 350 test as a vital decision‑support tool that must always be interpreted alongside clinical and radiological findings. A high TMB or MSI‑H result opens the door to immunotherapy, but the final treatment decision belongs to a multidisciplinary tumor board. Never alter any cancer therapy without thorough clinical correlation.”
— Dr. Prabhakar Reddy, DHA‑Licensed Oncologist (License: 61713011)
⚠ Medication Warning
Do not discontinue prescribed medication, including chemotherapy or targeted agents, without consulting your treating doctor. This test provides genomic insights, not an immediate substitute for ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
Sample Rejection Risks
- FFPE block with tumor content <10%
- Necrotic or heavily decalcified tissue
- Specimens fixed in non‑buffered formalin or inadequate fixation time
- Block received outside cold‑chain conditions
Immediate Medical Attention Required
- Sudden worsening of cancer symptoms (severe pain, breathing difficulty)
- Signs of spinal cord compression or brain metastasis (confusion, paralysis)
- Uncontrolled bleeding or febrile neutropenia
- Any acute adverse reaction to current therapy
* These red flags warrant immediate hospital evaluation regardless of pending test results.
Patient FAQ & Clinical Guidance
1. How does the ONCOPRO 350 guide my cancer treatment?
This 350‑gene assay measures tumor mutational burden and microsatellite instability, enabling your oncologist to select immunotherapy drugs like pembrolizumab if results show high TMB or MSI‑H. يقيس الاختبار حمل الطفرات الورمية وعدم استقرار الساتل الميكروي لتوجيه قرار استخدام العلاج المناعي والأدوية الموجهة بدقة.
2. Why does it take 45 working days to receive my report?
Comprehensive NGS sequencing, rigorous bioinformatics analysis, and multi‑disciplinary sign‑off ensure reliable results; every step follows ISO‑certified protocols and expert manual review. تسلسل 350 جينًا كاملاً، وتحليل المعلوماتية الحيوية المعقدة، والمراجعة البشرية من قبل أخصائي علم الأمراض الجزيئي يستغرق وقتاً لضمان الدقة.
3. Can I get tested if my biopsy is small or from a difficult location?
Yes, if the FFPE block contains at least 10% tumor nuclei and was fixed in neutral formalin; our pathologists pre‑qualify every sample before NGS. يمكن إجراء الاختبار طالما أن الكتلة النسيجية تحتوي على 10% على الأقل من أنوية الخلايا الورمية ومثبتة بالفورمالين المعتدل، ويتم تقييم العينة مسبقاً.
Federal Decree‑Law No. 41 of 2024 (Art. 87) • CDS Law 2026 (Minors) • UAE PDPL Data Privacy • ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) • DHA Facility License: 9834453 • Support: +971545488731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians